Merck Sharp an Dohme B.V v. Union of India
Case brief
What is this about?
pre-grant opposition; Rule 55(3); Rule 55(3)(b); Patents (Amendment) Rules 2024; Patents Rules 2003; Section 25(1) Patents Act 1970; mechanical issuance of notice; application of mind; prima facie satisfaction; time-bound disposal of patent application; successive oppositions; benami opposition; acalabrutinib; Calquence; Indian Patent Application No.408/CHENP/2014; Natco Pharma; Article 226; writ of certiorarified mandamus; Intellectual Property Division; Madras High Court.
What did the court decide?
Writ petition disposed with directions: (a) petitioner to file its reply to the 7th respondent's pre-grant opposition within four weeks; (b) 3rd respondent to decide the 1st, 2nd, 3rd and 4th pre-grant oppositions after affording an opportunity to the petitioner and the 7th respondent within three months thereafter; (c) any further pre-grant opposition during the interregnum to be dealt with strictly under Rule 55(3) of the Patents (Amendment) Rules, 2024 and not entertained absent a prima facie fresh ground; (d) 3rd respondent to comply with the timelines and pass final orders on the application on its own merits and in accordance with law; no order as to costs; connected Miscellaneous Petitions closed.